UNSPSC 51241537: Phenylephrine/sulfacetamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP900. This VA Drug Class (OP900) classifies this compound as belonging to the group OPHTHALMICS, OTHER.

UNSPSC 51241537 Phenylephrine/sulfacetamide is a Commodity code covering pharmaceutical products that state and local governments procure through cooperative purchasing vehicles and direct supply agreements. State and local buyers source specific pharmaceutical compositions identified by National Drug Codes and package configurations for distribution across government facilities, including hospitals, clinics, and health departments. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body active under this code, using cooperative purchasing agreements to aggregate demand across multiple participating states and local government facilities.

MMCAP's recent RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) illustrates current procurement activity under the code. The solicitation seeks manufacturers willing to supply identified pharmaceutical products through authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with pricing weighted heavily on competitiveness (75 percent), compliance with cGMP and Drug Supply Chain Security Act requirements, EDI capability, and fixed pricing structures. Award encompasses participating states including Minnesota and Oregon, with contracts effective July 1, 2026, and a two-year initial term. Vendors must maintain comprehensive insurance including $5,000,000 commercial general liability and demonstrate pricing flexibility through flat price or net price formats; performance penalties of $200 to $1,500 per violation apply for reporting delays or missed onboarding timelines. No specific dollar values or set-aside designations are disclosed in available documentation.